Key alerts to setup on GCP violations during the clinical trial

Life science companies conducting clinical trials must adhere to GCP guidelines to ensure the safety and well-being of study participants and maintain the integrity of the clinical trial data. To achieve this, it is essential to establish monitoring and alerting mechanisms to detect any violations of GCP guidelines.

Continue ReadingKey alerts to setup on GCP violations during the clinical trial